发明名称 |
Gotas oftálmicas para tratar infección ocular que contienen levofloxacino, sal del mismo o solvato del mismo, método de tratamiento de infección ocular, levofloxacino, sal del mismo o solvato del mismo, y su uso |
摘要 |
Instillation of a 1.5% (w/v) levofloxacin ophthalmic solution three times a day, which is the dosage or dose regimen of the present invention, has features to cure bacterial conjunctivitis in a shorter time than instillation of a 0.5% (w/v) ophthalmic solution three times a day, which is the conventional dosage or dose regimen, and not to increase the rate of occurrence of side effects. Curing the ocular infection in a short time leads to shortening of the duration of exposure of the ocular-infection-causing bacterium to levofloxacin. Therefore, the levofloxacin ophthalmic solution in the dosage or dose regimen of the present invention is eventually expected to suppress emergence of the resistant bacterium resulting from the long-term use of the levofloxacin ophthalmic solution in the conventional dosage or dose regimen. In addition, it is confirmed that the levofloxacin ophthalmic solution in the dosage or dose regimen of the present invention directly inhibits the ocular-infection-causing bacterium such as Staphylococcus aureus from becoming resistant to levofloxacin, which results from the short-term use of the levofloxacin ophthalmic solution in the conventional dosage or dose regimen. |
申请公布号 |
ES2568647(T3) |
申请公布日期 |
2016.05.03 |
申请号 |
ES20100846644T |
申请日期 |
2010.12.16 |
申请人 |
Santen Pharmaceutical Co., Ltd;Daiichi Sankyo Company, Limited |
发明人 |
NAGANO, Takashi;SAKANAKA, Koji;NAKAMURA, Masatsugu;KAWAZU, Kouichi;IBUKI, Hajime;SAKAMOTO, Kayoko |
分类号 |
A61K31/5383;A61P27/02;A61P31/04 |
主分类号 |
A61K31/5383 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|